search
Back to results

Comparing Pain and Bruising of Subcutaneous Heparin Injection

Primary Purpose

Pain, Bruising

Status
Terminated
Phase
Phase 2
Locations
Study Type
Interventional
Intervention
10s injections duration
10s injection duration and waiting 10s before withdrawing the needle
15s injection duration and waiting 5s before withdrawing the needle
5s injection duration and waiting 15s before withdrawing the needle
Sponsored by
Mashhad University of Medical Sciences
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Pain focused on measuring subcutaneous injection heparin, injection duration, bruising pain, decrease pain, decrease bruising

Eligibility Criteria

53 Years - 69 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Inclination to participate in the study; filling out the form of conscious satisfaction
  • Ability to answer the questions and determining the rate of pain
  • Not being affected by blood clotting difficulties, tissue damages, injuries, and bruises in the site of injection.

Exclusion Criteria:

  • Death,
  • Discharge

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm 3

    Arm 4

    Arm Type

    Experimental

    Experimental

    Experimental

    Experimental

    Arm Label

    10s injections duration

    10s injection duration , waiting 10s

    15s injection duration,waiting 5s

    5s injection duration , waiting 15s

    Arm Description

    10s injections duration

    10s injection duration and waiting 10s before withdrawing the needle

    15s injection duration and waiting 5s before withdrawing the needle

    5s injection duration and waiting 15s before withdrawing the needle

    Outcomes

    Primary Outcome Measures

    decrease pain
    pain was measured by pain visual analogue scale immediately after the injection.
    bruising
    Bruising was measured by a flexible millimeter ruler 48h after each injection

    Secondary Outcome Measures

    Full Information

    First Posted
    May 19, 2012
    Last Updated
    July 19, 2012
    Sponsor
    Mashhad University of Medical Sciences
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT01645774
    Brief Title
    Comparing Pain and Bruising of Subcutaneous Heparin Injection
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    June 2012
    Overall Recruitment Status
    Terminated
    Study Start Date
    January 2011 (undefined)
    Primary Completion Date
    June 2012 (Actual)
    Study Completion Date
    June 2012 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Mashhad University of Medical Sciences

    4. Oversight

    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    Subcutaneous heparin injection is one of the most frequent nurses' clinical care. This study aimed to Identify and compare the effects of four different injection duration on pain and bruising associated with subcutaneous injection of heparin in 90 patients. Four injection methods were used for them: A: 10s injections duration B: 10s injection duration and waiting 10s before withdrawing the needle C: 15s injection duration and waiting 5s before withdrawing the needle D: 5s injection duration and waiting 15s before withdrawing the needle. Bruising was measured by a flexible millimeter ruler 48h after each injection; and pain was measured by pain visual analogue scale immediately after the injection. Data will be analyzed by SPSS.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Pain, Bruising
    Keywords
    subcutaneous injection heparin, injection duration, bruising pain, decrease pain, decrease bruising

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Phase 2, Phase 3
    Interventional Study Model
    Single Group Assignment
    Masking
    ParticipantCare Provider
    Allocation
    Randomized
    Enrollment
    90 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    10s injections duration
    Arm Type
    Experimental
    Arm Description
    10s injections duration
    Arm Title
    10s injection duration , waiting 10s
    Arm Type
    Experimental
    Arm Description
    10s injection duration and waiting 10s before withdrawing the needle
    Arm Title
    15s injection duration,waiting 5s
    Arm Type
    Experimental
    Arm Description
    15s injection duration and waiting 5s before withdrawing the needle
    Arm Title
    5s injection duration , waiting 15s
    Arm Type
    Experimental
    Arm Description
    5s injection duration and waiting 15s before withdrawing the needle
    Intervention Type
    Procedure
    Intervention Name(s)
    10s injections duration
    Intervention Description
    10s injections duration
    Intervention Type
    Procedure
    Intervention Name(s)
    10s injection duration and waiting 10s before withdrawing the needle
    Intervention Description
    10s injection duration and waiting 10s before withdrawing the needle
    Intervention Type
    Procedure
    Intervention Name(s)
    15s injection duration and waiting 5s before withdrawing the needle
    Intervention Description
    15s injection duration and waiting 5s before withdrawing the needle
    Intervention Type
    Procedure
    Intervention Name(s)
    5s injection duration and waiting 15s before withdrawing the needle
    Intervention Description
    5s injection duration and waiting 15s before withdrawing the needle
    Primary Outcome Measure Information:
    Title
    decrease pain
    Description
    pain was measured by pain visual analogue scale immediately after the injection.
    Time Frame
    up to 6 months
    Title
    bruising
    Description
    Bruising was measured by a flexible millimeter ruler 48h after each injection
    Time Frame
    up to 6 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    53 Years
    Maximum Age & Unit of Time
    69 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Inclination to participate in the study; filling out the form of conscious satisfaction Ability to answer the questions and determining the rate of pain Not being affected by blood clotting difficulties, tissue damages, injuries, and bruises in the site of injection. Exclusion Criteria: Death, Discharge

    12. IPD Sharing Statement

    Learn more about this trial

    Comparing Pain and Bruising of Subcutaneous Heparin Injection

    We'll reach out to this number within 24 hrs